ECONOMY

As we inch closer to the new year, data for 2025 is gradually coming into focus. This year's most-read books and most-watched films have been identified, and now, the wealthiest individuals of the year have also been revealed. Intriguing details have emerged from the data provided by Forbes and the Hurun Global Rich List. The countries and cities where billionaires prefer to reside this year have been determined according to the data for 2025.In addition to America and Europe, let's see which Asian countries have managed to climb to the top this year?

In recent years, silver, which has provided its investors with returns surpassing that of gold, has shattered yet another record. The per ounce value of silver has soared to an all-time high of 60 dollars. In Turkey, the price of silver per gram has escalated up to 82 lira. The primary reasons behind the surge in silver are believed to be expectations of interest rate cuts and ongoing supply constraints in the market.

Citizens investing in precious metals like gold and silver are keeping a close eye on the reports and predictions of experts. Most recently, the German banking giant, Commerzbank, has raised its forecast for gold and silver prices in a published report. The bank has revised its previous expectation for gold in 2026 from $4,200 to $4,400. Moreover, it has announced an expectation of $59 for silver. As of today, the price of an ounce of gold is trading at $4,224, while in Turkey, the price of a gram of gold has surged to 5,760 liras.

Despite suffering serious losses in the past, Japanese individual investors have once again turned their attention to the Turkish lira. The lira, which has lost more than 16% of its value against the yen this year, has become one of the most traded assets among risk-hungry day traders in Tokyo.According to data from the Tokyo Financial Exchange, as of November 12, approximately 900,000 futures margin contracts linked to the lira-yen pair have been opened. This figure is hovering near its all-time highs. Experts are cautioning that the expectation of high returns could potentially lead investors into the risk of another collective loss.

BillionToOne, a biotech firm established by Turkish entrepreneur Oğuzhan Atay in 2016, made its public debut on Nasdaq just the other day. Founded with the aim of developing genetic tests conducted via blood samples for common diseases such as sickle cell anemia and cystic fibrosis, the company has been a source of joy for its investors from day one. By the close of its first day of trading, the share price of the company, which started at $60, soared to $109, pushing the company's market value up to a staggering $5.8 billion.